Neuropsychopharmacology Reports

Wiley

Evaluation status available after sign-in

About the journal

Neuropsychopharmacology Reports is an open-access journal published by Wiley in Australia, publishing in english. It is listed in DOAJ and MEDLINE according to the sources read. Declared publication charge: 2,500 USD. Declared review time at DOAJ: 14 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher: Wiley
ISSN: 2574-173X
Country: Australia
Languages: english
Access: Open access
Declared publication charge: 2,500 USD
Articles in DOAJ: 625
Declared review time: 14 weeks
Declared peer-review model: other
Official website: https://onlinelibrary.wiley.com/journal/2574173x

Index listings

DOAJ · 2018-08-20
MEDLINE · 2018-01-01

Indexing: DOAJ · MEDLINE
APC: 2,500 USD
Declared review time (DOAJ): 14 weeks
Actual review time (measured): 136 days received→accepted — computed from PubMed (n=96)
Activity (OpenAlex): Active — latest works 2026
PublishLens list status: Shown after sign-in
Counts for promotion at your university?: Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Articles in DOAJ

625

Most recent article

4 months ago

Average review time (journal-declared via DOAJ)

14weeks

Works in OpenAlex

706

Last recorded publication year

2026

Reported by OpenAlex in 2 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

i10-index

158

From OpenAlex open data (CC0).

Editorial & policy13

Last DOAJ review date: 2026-03-17
Added to DOAJ: 2018-08-20
Declared plagiarism screening: Declared
Other fees beyond APC: No
Declared digital preservation: CLOCKSSPorticoPMC
Observed digital preservation (Keepers registry)— snapshot 2026-10-05: CLOCKSSPortico
Editorial board: Official page ↗
Norwegian register (HK-dir)— 2026: Level 1 — approved scholarly channel
Open references deposited at Crossref: 89%
ORCID iDs in current deposits: 87%
Enrolled in Crossref Similarity Check: ✓
Deposits licence metadata at Crossref: ✓
APC waiver policy: View policy
Peer-review policy: View policy

Identity & continuity4

Alternate titles: Neuropsychopharmacol Rep
Source type: journal
NLM unique ID (PubMed): 101719700
Society affiliations: The Japanese Society of Neuropsychopharmacology

Classification4

Subjects (DOAJ)

Medicine: Therapeutics. PharmacologyMedicine: Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry

LCC codes

RM1-950RC321-571

Subject areas

Schizophrenia research and treatment
Schizophrenia research and treatment
Schizophrenia research and treatment
Treatment of Major Depression
Neurotransmitter Receptor Influence on Behavior
Substance Abuse Treatment and Outcomes
Treatment of Major Depression
Neurotransmitter Receptor Influence on Behavior

Show all subjects (75)

Neurotransmitter Receptor Influence on Behavior
Treatment of Major Depression
Tryptophan and brain disorders
Tryptophan and brain disorders
Neuroscience and Neuropharmacology Research
Attention Deficit Hyperactivity Disorder
Attention Deficit Hyperactivity Disorder
Bipolar Disorder and Treatment
Sleep and related disorders
Bipolar Disorder and Treatment
Sleep and related disorders
Bipolar Disorder and Treatment
Electroconvulsive Therapy Studies
Substance Abuse Treatment and Outcomes
Electroconvulsive Therapy Studies
Substance Abuse Treatment and Outcomes
Electroconvulsive Therapy Studies
Mental Health and Psychiatry
Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
Tryptophan and brain disorders
Neuroscience and Neuropharmacology Research
Neuroscience and Neuropharmacology Research
Sleep and Wakefulness Research
Opioid Use Disorder Treatment
Sleep and related disorders
Sleep and Wakefulness Research
Dementia and Cognitive Impairment Research
Attention Deficit Hyperactivity Disorder
Mental Health Treatment and Access
Forensic Toxicology and Drug Analysis
Forensic Toxicology and Drug Analysis
COVID-19 and Mental Health
Pain Management and Opioid Use
Autism Spectrum Disorder Research
Stress Responses and Cortisol
Stress Responses and Cortisol
Autism Spectrum Disorder Research
Autism Spectrum Disorder Research
Alcoholism and Thiamine Deficiency
Epilepsy research and treatment
Stress Responses and Cortisol
Opioid Use Disorder Treatment
Alcoholism and Thiamine Deficiency
Cholinesterase and Neurodegenerative Diseases
Cannabis and Cannabinoid Research
Cholinesterase and Neurodegenerative Diseases
Opioid Use Disorder Treatment
Cannabis and Cannabinoid Research
Healthcare Decision-Making and Restraints
Pharmacogenetics and Drug Metabolism
Epilepsy research and treatment
Healthcare Decision-Making and Restraints
Mental Health Treatment and Access
Alzheimer's disease research and treatments
Suicide and Self-Harm Studies
Maternal Mental Health During Pregnancy and Postpartum
Transcranial Magnetic Stimulation Studies
Forensic Toxicology and Drug Analysis
Mental Health Treatment and Access
Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
Memory and Neural Mechanisms
Functional Brain Connectivity Studies
Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
Psychedelics and Drug Studies
Functional Brain Connectivity Studies
Memory and Neural Mechanisms
Psychedelics and Drug Studies

Keywords (DOAJ)

psychopharmacology
neurology
neuropsychology
psychiatry
pharmacology

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…

How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJL DOAJ